KRAS and colorectal neoplasm: In fact, it should be considered that, in colorectal tumors, the presence of several mutations is frequent, and the association of these mutations (for example, KRAS/p16, KRAS/p53, and others) could give the disease a distinct biological attitude that translates into a different clinical aggressiveness.